Related Experiment Videos
Expression of monocyte chemoattractant protein-1 in experimental crescentic glomerulonephritis in rats
M Sekiguchi1, Y Natori, K Iyonaga
1Division of Pathophysiology, Research Institute, International Medical Center of Japan, Tokyo.
Insights
Monocyte chemoattractant protein-1 (MCP-1) is upregulated in crescentic glomerulonephritis (CGN). Glomeruli produce MCP-1, crucial for monocyte infiltration and inflammation in CGN.
Area of Science:
- Nephrology
- Immunology
- Pathology
Background:
- Crescentic glomerulonephritis (CGN) is a severe kidney disease with poor prognosis.
- Monocytes/macrophages are key players in CGN pathogenesis.
- Monocyte chemoattractant protein-1 (MCP-1) attracts monocytes.
Purpose of the Study:
- To investigate glomerular MCP-1 expression in an experimental CGN model.
- To determine MCP-1's role in CGN inflammation and crescent formation.
Main Methods:
- Induced CGN in WKY rats using anti-GBM antiserum.
- Analyzed glomerular MCP-1 mRNA and protein expression via Northern blot and ELISA.
- Used MCP-1-specific antibodies for immunostaining.
Main Results:
- Monocyte/macrophage accumulation observed within 4 hours post-induction.
- Glomerular MCP-1 mRNA expression increased significantly, peaking on day 3.
- Elevated MCP-1 protein levels detected in diseased glomeruli, correlating with mRNA levels.
Conclusions:
- Glomeruli in CGN actively produce MCP-1.
- MCP-1 likely contributes significantly to glomerular inflammation and crescent formation in CGN.
Abstract:
Crescentic glomerulonephritis (CGN) is a rapidly progressive glomerular disease that is usually associated with a poor prognosis. Monocytes/macrophages are frequently observed in glomeruli in cases of CGN, and they are considered to play a crucial role in the pathogenesis of this disease. In this study we analyzed the glomerular expression of monocyte chemoattractant protein-1 (MCP-1), a potent chemoattractant for monocytes, in an experimental model of CGN. A model of the disease was induced in the WKY strain of rats by intravenous injection of antiserum raised against glomerular basement membranes. Accumulation of monocytes/macrophages in glomeruli was observed 4 hours after the injection of antiserum. Northern blot analysis showed that the expression of mRNA for MCP-1 was enhanced within 4 hours, peaked on day 3--when it was 60 times that in the control--and then declined. Immunostaining with MCP-1-specific antibody revealed the expression of MCP-1 protein in the diseased glomeruli but not in control glomeruli. Quantitative analysis of glomerular MCP-1 protein by enzyme-linked immunosorbent assay revealed a level 46 times that in the control in reflecting the increase in mRNA for MCP-1. These results indicate that glomeruli of rats with CGN produce MCP-1, which may play an important role in the pathogenesis of glomerular inflammation and crescent formation in CGN.